AmerisourceBergen Corporation

Symbol: ABC

NYSE

179.98

USD

Market price today

  • 19.4567

    P/E Ratio

  • -0.4234

    PEG Ratio

  • 36.15B

    MRK Cap

  • 0.01%

    DIV Yield

AmerisourceBergen Corporation (ABC) Stock Price & Analysis

Shares Outstanding

200.85M

Gross Profit Margin

0.03%

Operating Profit Margin

0.01%

Net Profit Margin

0.01%

Return on Assets

0.03%

Return on Equity

2.48%

Return on Capital Employed

0.20%

Company general description and statistics

Sector: Healthcare
Industry: Medical Distribution
CEO:Mr. Steven H. Collis
Full-time employees:46000
City:Conshohocken
Address:1 West First Avenue
IPO:1995-04-04
CIK:0001140859

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

General Outlook

In simple terms, AmerisourceBergen Corporation has 200.854 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.034% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.010%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.007%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.029% return, is a testament to AmerisourceBergen Corporation's adeptness in optimizing resource deployment. AmerisourceBergen Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 2.480%. Furthermore, the proficiency of AmerisourceBergen Corporation in capital utilization is underscored by a remarkable 0.195% return on capital employed.

Stock Prices

AmerisourceBergen Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $177.08, while its low point bottomed out at $174.22. This variance in figures offers investors a lucid insight into the roller-coaster ride that is AmerisourceBergen Corporation's stock market.

Liquidity Ratios

Analyzing ABC liquidity ratios reveals its financial health of the firm. The current ratio of 88.35% gauges short-term asset coverage for liabilities. The quick ratio (48.15%) assesses immediate liquidity, while the cash ratio (5.66%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio88.35%
Quick Ratio48.15%
Cash Ratio5.66%

Profitability Ratios

ABC profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 0.87% underscores its earnings before tax deductions. The effective tax rate stands at 20.90%, revealing its tax efficiency. The net income per EBT, 79.42%, and the EBT per EBIT, 86.47%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.00%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin0.87%
Effective Tax Rate20.90%
Net Income per EBT79.42%
EBT per EBIT86.47%
EBIT per Revenue1.00%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.88, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding48
Days of Inventory Outstanding26
Operating Cycle54.95
Days of Payables Outstanding66
Cash Conversion Cycle-11
Receivables Turnover12.59
Payables Turnover5.49
Inventory Turnover14.06
Fixed Asset Turnover128.27
Asset Turnover4.20

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 12.04, and free cash flow per share, 9.77, depict cash generation on a per-share basis. The cash per share value, 14.23, showcases liquidity position. A payout ratio of 0.11 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.01, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share12.04
Free Cash Flow per Share9.77
Cash per Share14.23
Payout Ratio0.11
Operating Cash Flow Sales Ratio0.01
Free Cash Flow to Operating Cash Flow Ratio0.81
Cash Flow Coverage Ratio0.51
Short Term Coverage Ratio4.10
Capital Expenditure Coverage Ratio5.32
Dividend Paid and Capex Coverage Ratio3.69

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 7.39%, highlights its total liabilities relative to assets. With a debt-equity ratio of 5.24, we discern the balance between debt and equity financing. The long-term debt to capitalization, 82.12%, and total debt to capitalization, 83.98%, ratios shed light on its capital structure. An interest coverage of 12.16 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio7.39%
Debt Equity Ratio5.24
Long Term Debt to Capitalization82.12%
Total Debt to Capitalization83.98%
Interest Coverage12.16
Cash Flow to Debt Ratio0.51
Company Equity Multiplier70.96

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1281.45, provides a glimpse into top-line earnings distributed across each share. Net income per share, 8.53, reflects the portion of profit attributed to each share. The book value per share, 2.55, represents the net asset value distributed per share, while the tangible book value per share, -65.91, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1281.45
Net Income Per Share8.53
Book Value Per Share2.55
Tangible Book Value Per Share-65.91
Shareholders Equity Per Share2.55
Interest Debt Per Share24.52
Capex Per Share-2.24

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.50%, indicates top-line expansion, while the gross profit growth, 19.49%, reveals profitability trends. EBIT growth, 0.52%, and operating income growth, 0.52%, offer insights into operational profitability progression. The net income growth, 10.32%, showcases bottom-line expansion, and the EPS growth, 8.96%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth11.50%
Gross Profit Growth19.49%
EBIT Growth0.52%
Operating Income Growth0.52%
Net Income Growth10.32%
EPS Growth8.96%
EPS Diluted Growth8.80%
Weighted Average Shares Growth1.24%
Weighted Average Shares Diluted Growth1.32%
Dividends per Share Growth5.52%
Operating Cash Flow Growth1.37%
Free Cash Flow Growth-0.97%
10-Year Revenue Growth per Share264.12%
5-Year Revenue Growth per Share63.19%
3-Year Revenue Growth per Share33.93%
10-Year Operating CF Growth per Share151.20%
5-Year Operating CF Growth per Share90.16%
3-Year Operating CF Growth per Share16.25%
10-Year Net Income Growth per Share186.64%
5-Year Net Income Growth per Share329.33%
3-Year Net Income Growth per Share100.22%
10-Year Shareholders Equity Growth per Share-114.31%
5-Year Shareholders Equity Growth per Share-114.36%
3-Year Shareholders Equity Growth per Share-109.76%
10-Year Dividend per Share Growth per Share257.92%
5-Year Dividend per Share Growth per Share28.11%
3-Year Dividend per Share Growth per Share16.49%
Receivables Growth0.35%
Inventory Growth1.22%
Asset Growth-1.36%
Book Value per Share Growth-228.15%
Debt Growth-14.68%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 40,498,933,020, captures the company's total value, considering both debt and equity. Income quality, 0.75, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 22.39%, indicates the value of non-physical assets, and capex to operating cash flow, -35.14%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value40,498,933,020
Income Quality0.75
Intangibles to Total Assets22.39%
Capex to Operating Cash Flow-35.14%
Capex to Revenue-0.17%
Capex to Depreciation-109.44%
Graham Number22.13
Return on Tangible Assets3.59%
Graham Net Net-171.24
Working Capital-6,032,372,000
Tangible Asset Value-13,483,897,000
Net Current Asset Value-19,237,917,000
Invested Capital9
Average Receivables19,681,878,000
Average Payables43,014,463,500
Average Inventory16,505,581,000
Days Sales Outstanding29
Days Payables Outstanding66
Days of Inventory On Hand25
ROIC35.35%
ROE3.34%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 39.84, and the price to book ratio, 39.84, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.13, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 18.33, and price to operating cash flows, 14.95, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio39.84
Price to Book Ratio39.84
Price to Sales Ratio0.13
Price Cash Flow Ratio14.95
Price Earnings to Growth Ratio-0.42
Enterprise Value Multiple9.63
Price Fair Value39.84
Price to Operating Cash Flow Ratio14.95
Price to Free Cash Flows Ratio18.33
Price to Tangible Book Ratio73.38
Enterprise Value to Sales0.15
Enterprise Value Over EBITDA12.03
EV to Operating Cash Flow31.05
Earnings Yield4.56%
Free Cash Flow Yield2.21%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of AmerisourceBergen Corporation (ABC) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 19.457 in 2024.

What is the ticker symbol of AmerisourceBergen Corporation stock?

The ticker symbol of AmerisourceBergen Corporation stock is ABC.

What is company IPO date?

IPO date of AmerisourceBergen Corporation is 1995-04-04.

What is company current share price?

Current share price is 179.980 USD.

What is stock market cap today?

The market cap of stock today is 36149702920.000.

What is PEG ratio in 2024?

The current -0.423 is -0.423 in 2024.

What is the number of employees in 2024?

In 2024 the company has 46000.